Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
7.45
-0.37 (-4.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Phathom Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 26.27 | 0.68 | - | - | - | - | |
| Cost of Revenue | 4.33 | 0.17 | - | - | - | - | |
| Gross Profit | 21.95 | 0.52 | - | - | - | - | |
| Selling, General & Admin | 270.98 | 117.93 | 101 | 62.74 | 27.52 | 6.94 | |
| Research & Development | 38.89 | 49.9 | 71.44 | 72.34 | 98.15 | 20.37 | |
| Operating Expenses | 309.87 | 167.83 | 172.44 | 135.08 | 125.67 | 27.32 | |
| Operating Income | -287.93 | -167.31 | -172.44 | -135.08 | -125.67 | -27.32 | |
| Interest Expense | -66.45 | -41.97 | -27.31 | -6.79 | -4.58 | -4.18 | |
| Interest & Investment Income | 15 | 7.88 | 2.13 | 0.04 | 1.09 | 1.09 | |
| Other Non Operating Income (Expenses) | -0.07 | -0.19 | -0.11 | -0.06 | 0.09 | -96.28 | |
| EBT Excluding Unusual Items | -339.45 | -201.59 | -197.72 | -141.88 | -129.07 | -126.69 | |
| Other Unusual Items | - | - | - | -2 | - | -49.55 | |
| Pretax Income | -339.45 | -201.59 | -197.72 | -143.88 | -129.07 | -255.13 | |
| Net Income | -339.45 | -201.59 | -197.72 | -143.88 | -129.07 | -255.13 | |
| Net Income to Common | -339.45 | -201.59 | -197.72 | -143.88 | -129.07 | -255.13 | |
| Shares Outstanding (Basic) | 60 | 51 | 39 | 37 | 33 | 11 | |
| Shares Outstanding (Diluted) | 60 | 51 | 39 | 37 | 33 | 11 | |
| Shares Change (YoY) | 26.36% | 31.11% | 5.72% | 11.36% | 192.32% | 87.83% | |
| EPS (Basic) | -5.68 | -3.93 | -5.05 | -3.89 | -3.88 | -22.45 | |
| EPS (Diluted) | -5.68 | -3.93 | -5.05 | -3.89 | -3.88 | -22.45 | |
| Free Cash Flow | -247.72 | -139.21 | -147.57 | -148.79 | -70.73 | -36.64 | |
| Free Cash Flow Per Share | -4.15 | -2.71 | -3.77 | -4.02 | -2.13 | -3.22 | |
| Gross Margin | 83.54% | 75.51% | - | - | - | - | |
| Operating Margin | -1096.02% | -24532.55% | - | - | - | - | |
| Profit Margin | -1292.14% | -29558.94% | - | - | - | - | |
| Free Cash Flow Margin | -942.96% | -20412.61% | - | - | - | - | |
| EBITDA | -287.14 | -166.74 | -171.82 | -134.56 | -125.34 | -27.31 | |
| D&A For EBITDA | 0.79 | 0.58 | 0.62 | 0.52 | 0.32 | 0.01 | |
| EBIT | -287.93 | -167.31 | -172.44 | -135.08 | -125.67 | -27.32 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.